Syneos Health, Inc.
SYNHDelisted Sep 28, 2023- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001610950
Syneos Health, Inc. was delisted on Sep 28, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 317 institutions reported holding it in 13F filings for Q2 2023, worth $4.32B in total; superinvestors Elliott Investment Management and Southeastern Asset Management (Longleaf) held it.
13F holders, Q2 2022
Institutional positions in Syneos Health, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 363
- +9 vs. Q1 2022
- Shares held
- 97.6M
- +596.7K (+0.6%) vs. Q1 2022
- Total value
- $7.00B
- −$853.3M (−10.9%) vs. Q1 2022
- New holders
- 43
- 144 more added
- Sold out
- 34
- 127 more reduced
11 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SYNH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $43 |
| Q1 2026 | 1 | $43 |
| Q4 2025 | 1 | $43 |
| Q3 2025 | 1 | $43 |
| Q2 2025 | 1 | $43 |
| Q1 2025 | 1 | $43 |
| Q4 2024 | 1 | $43 |
| Q3 2024 | 1 | $43 |
| Q2 2024 | 1 | $43 |
| Q1 2024 | 1 | $43 |
| Q4 2023 | 2 | $1.03K |
| Q3 2023 | 10 | $9.16M |
| Q2 2023 | 317 | $4.32B |
| Q1 2023 | 306 | $3.69B |
| Q4 2022 | 306 | $3.78B |
| Q3 2022 | 337 | $4.58B |
| Q2 2022 | 363 | $7.00B |
| Q1 2022 | 365 | $7.90B |
| Q4 2021 | 378 | $10.2B |
| Q3 2021 | 356 | $8.73B |
| Q2 2021 | 342 | $9.12B |
| Q1 2021 | 319 | $7.97B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Syneos Health, Inc.; share changes are against Q1 2022.